Vaccinex, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Vaccinex, Inc. (VCNX) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of $76.93 per share for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2025-04-15
- Vaccinex, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2024-03-31 was $626.18, a 10318.97% increase year-over-year.
- Vaccinex, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2023-03-31 was $6.01, a 14.04% increase year-over-year.
- Vaccinex, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2022-03-31 was $5.27, a 5.40% increase year-over-year.
- Vaccinex, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2021-03-31 was $5.00, a 41.45% decline year-over-year.
- Vaccinex, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2024 was $76.93, a 74.60% decline from fiscal 2023.
- Vaccinex, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2023 was $302.87, a 54.64% decline from fiscal 2022.
- Vaccinex, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2022 was $667.66, a 11780.07% increase from fiscal 2021.
- Vaccinex, Inc. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2021 was $5.62, a 3.44% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $76.93 10-K · filed 2025-04-15 | ||||
| 2024-09-30 | $212.95 10-Q · filed 2024-11-14 | ||||
| 2024-06-30 | $983.95 10-Q · filed 2024-08-14 | ||||
| 2024-03-31 | $626.18 10-Q · filed 2024-05-15 | ||||
| 2023-12-31 | $302.87 10-K · filed 2025-04-15 | ||||
| 2023-09-30 | $90.71 10-Q · filed 2023-11-13 | ||||
| 2023-06-30 | $6.01 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | $6.01 10-Q · filed 2023-05-15 | ||||
| 2022-12-31 | $667.66 10-K/A · filed 2024-04-25 | $3.20 10-K · filed 2023-03-31 | |||
| 2022-09-30 | $4.37 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | $4.37 10-Q · filed 2022-08-15 | ||||
| 2022-03-31 | $5.27 10-Q · filed 2022-05-16 | ||||
| 2021-12-31 | $5.62 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $5.83 10-Q · filed 2021-11-08 | ||||
| 2021-06-30 | $5.83 10-Q · filed 2021-08-16 | ||||
| 2021-03-31 | $5.00 10-Q · filed 2021-05-17 | ||||
| 2020-12-31 | $5.82 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $8.10 10-Q · filed 2020-11-13 | ||||
| 2020-06-30 | $8.10 10-Q · filed 2020-08-14 | ||||
| 2020-03-31 | $8.54 10-Q · filed 2020-05-14 | ||||
| 2019-12-31 | $9.86 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | $10.07 10-Q · filed 2019-11-12 | ||||
| 2019-06-30 | $13.01 10-Q · filed 2019-08-14 | ||||
| 2019-03-31 | $12.60 10-Q · filed 2019-05-15 | ||||
| 2018-12-31 | $7.10 10-K · filed 2020-03-09 | ||||
| 2018-09-30 | $7.10 10-Q · filed 2018-11-13 | ||||
| 2018-06-30 | $7.10 10-Q · filed 2018-08-14 | ||||
| 2017-12-31 | $14.60 10-K · filed 2019-03-13 |